GUSBP17: A Drug Target / Disease Biomarker (G100049076)

Target Name: GUSBP17

NCBI ID: G100049076

GUSBP17

Other Name(s): GUSB pseudogene 17 | GUSBP9

GUSBP17: A Drug Target / Disease Biomarker

GUSBP17 is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a member of the GUSBP gene family, which is known for the production of glycoproteins that are involved in various physiological processes in the body. One of the unique features of GUSBP17 is its ability to interact with other proteins, which has led to its potential as a drug target or biomarker.

GUSBP17 has been shown to play a role in a variety of biological processes, including cell signaling, protein synthesis, and inflammation. Its interaction with other proteins has been shown to be involved in the regulation of cell growth, differentiation, and survival.

One of the most promising aspects of GUSBP17 as a drug target is its ability to interact with multiple proteins, including tyrosine kinases, which are involved in a variety of cellular processes, including cell signaling and survival. This suggests that GUSBP17 could be a useful target for therapies aimed at modulating tyrosine kinase activity.

In addition to its potential as a drug target, GUSBP17 has also been shown to be a potential biomarker for a variety of diseases. Its expression has been shown to be elevated in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This suggests that GUSBP17 could be a useful biomarker for these diseases, and that its levels could be used as a diagnostic tool.

GUSBP17 has also been shown to play a role in the regulation of protein synthesis and translation. Its interaction with the protein translation factor eIF4F has been shown to be involved in the regulation of protein synthesis and translation, which could have implications for the treatment of various diseases.

In conclusion, GUSBP17 is a protein that has the potential to be a drug target or biomarker. Its interaction with multiple proteins and its ability to regulate protein synthesis and translation make it an attractive target for therapies aimed at modulating cellular processes. Further research is needed to fully understand the role of GUSBP17 in these processes and its potential as a drug or biomarker.

Protein Name: GUSB Pseudogene 17

The "GUSBP17 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GUSBP17 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.tech.

More Common Targets